Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center
about
Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infectionCurrent Microbiology of Surgical Site Infections in Patients with Cancer: A Retrospective ReviewInvasive gram-positive bacterial infection in cancer patients.Is it time to replace vancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections?The effect of age and weight on vancomycin serum trough concentrations in pediatric patients.Antibiotic resistance in cancer patients.The challenge of antibiotic resistance in haematology patients.Optimizing Symptoms and Management of Febrile Neutropenia among Cancer Patients: Current Status and Future Directions.In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC "Neutropenia, Infection and Myelosuppression" Study Group during the MASCC annual meeting held in Berlin on 27-29 June 2013.Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.Daptomycin use in neutropenic patients with documented gram-positive infections.Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16).
P2860
Q34596203-3B5F903F-F52D-426F-AE80-2B236C038D97Q34726054-02023617-D05A-4C49-8258-F51EE7D30730Q34999884-58EA0240-278A-4555-BB3D-EE8DCDA3166AQ36856946-96F3295B-6C12-4B6A-923E-C26229C4D51AQ37347361-B4B4DE0D-D8C1-4D1B-986B-58DDC0FEFF55Q38212258-C38C131A-CE22-45C0-AFEF-EDF4DA911B82Q38613929-632B36FA-7D78-4F6B-BBEE-CFD23382DD41Q38749061-7FF3C982-4E62-42A5-954F-9AF7938EDFA3Q40252885-8450EFB6-093E-4CDB-8CC5-2937A38E4EE2Q40706134-A9F5CCA8-EEC9-40DE-A256-875762784343Q41158049-1E17CA56-4D9A-48D0-97AB-88FB6AE76994Q42215430-363757CB-B6AE-4F0B-BCCE-5E6E14B77B48Q42249906-2889EDFA-66D6-4C17-A621-4A20EED582DCQ54293201-48F40DD1-67BB-4C4C-8696-B24D38EB3176
P2860
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Characteristics and outcomes o ...... a comprehensive cancer center
@ast
Characteristics and outcomes o ...... a comprehensive cancer center
@en
type
label
Characteristics and outcomes o ...... a comprehensive cancer center
@ast
Characteristics and outcomes o ...... a comprehensive cancer center
@en
prefLabel
Characteristics and outcomes o ...... a comprehensive cancer center
@ast
Characteristics and outcomes o ...... a comprehensive cancer center
@en
P2093
P2860
P1433
P1476
Characteristics and outcomes o ...... a comprehensive cancer center
@en
P2093
Frank Tverdek
Issam I Raad
Javier A Adachi
Jharna N Shah
Kenneth V Rolston
Ray Hachem
Roy F Chemaly
Sminil N Mahajan
Victor Mulanovich
P2860
P304
P356
10.1634/THEONCOLOGIST.2012-0029
P577
2012-06-15T00:00:00Z